Synthesis of [C2H3]methotrexate and [C2H3]7-hydroxymethotrexate

被引:3
作者
Elmore, CS [1 ]
Dean, DC [1 ]
Zhang, Y [1 ]
Gibson, C [1 ]
Jenkins, H [1 ]
Jones, AN [1 ]
Melillo, DG [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
关键词
methotrexate; 7-hydroxymethotrexate; rofecoxib; cyclooxygenase II; reductive amination;
D O I
10.1002/jlcr.537
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Stable label analogues of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) were required for use as internal standards for LC/MS quantitation. A minimum incorporation of stable isotopes to produce a mass increase of 3 in the non-glutamate derived portion of the molecule was necessary for adequate MS detection. The commercial availability of desmethyl MTX (aminopterin, 1) made methylation with C2H3I an attractive option. Surprisingly, all attempted methylations of 1 and the dimethyl ester of 1 failed to provide a significant amount of the methylated aniline, apparently due to attenuated reactivity of the secondary amine towards alkylation. However, reductive amination of diacid 1 with (CH2O)-H-2 and (NaBH3CN)-H-2 gave [(CH3)-H-2]MTX in 52% yield. A previously reported method was utilized to convert [(CH3)-H-2]MTX to [(CH3)-H-2]7-OH-MTX. Preparative HPLC purification of [(CH3)-H-2]7-OH-MTX resulted in extremely low recovery from the column; this was resolved by switching to a column with few free silanols. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 9 条
[1]   POTENTIATION OF METHOTREXATE-INDUCED GASTROINTESTINAL TOXICITY BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND VINCRISTINE [J].
BADR, MZ ;
CHEN, TS .
TOXICOLOGY, 1985, 34 (04) :333-340
[2]  
BERTINO JR, 1997, CANC MED, P907
[3]  
CHEUNG HTA, 1987, HETEROCYCLES, V25, P507
[4]  
DALY H, 1986, LANCET, V327, P557
[5]   METHOTREXATE TOXICITY PRECIPITATED BY AZAPROPAZONE [J].
DALY, HM ;
SCOTT, GL ;
BOYLE, J ;
ROBERTS, CJC .
BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (06) :733-735
[6]   SYNTHESIS OF THE 7-HYDROXY METABOLITES OF METHOTREXATE AND 10-ETHYL-10-DEAZAAMINOPTERIN [J].
DAWSON, MI ;
OKRONGLY, D ;
HOBBS, PD ;
BARRUECO, JR ;
SIROTNAK, FM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) :635-638
[7]  
HUANG KC, 1979, CANCER RES, V39, P4843
[8]  
SINGH RR, 1986, LANCET, V1, P1390
[9]  
THYSS A, 1986, LANCET, V1, P256